Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry

被引:10
作者
Zubaid, Mohammad [1 ]
Khraishah, Haitham [2 ]
Alahmad, Barrak [3 ]
Rashed, Wafa [4 ]
Ridha, Mustafa [5 ]
Alenezi, Fahad [6 ]
Aljarralah, Mohamad [7 ]
Al-Marri, Khalid [8 ]
Almutairi, Mohammad [9 ]
Althalji, Khalid [6 ]
Alfaddagh, Abdulhamied [10 ]
机构
[1] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, TH Chan Sch Publ Hlth, Environm Hlth Dept, Boston, MA 02115 USA
[4] Minist Hlth, Dept Med, Div Cardiol, Mubarak Alkabeer Hosp, Kuwait, Kuwait
[5] Minist Hlth, Dept Cardiol, Salman Aldabous Cardiac Ctr, Kuwait, Kuwait
[6] Minist Hlth, Dept Med, Div Cardiol, Alfarwaniya Hosp, Kuwait, Kuwait
[7] Minist Hlth, Dept Cardiol, Sabah Alahmad Cardiac Ctr, Kuwait, Kuwait
[8] Minist Hlth, Dept Cardiol, Chest Dis Hosp, Kuwait, Kuwait
[9] Aljahra Hosp, Dept Med, Div Cardiol, Kuwait, Kuwait
[10] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
来源
ANNALS OF GLOBAL HEALTH | 2020年 / 86卷 / 01期
关键词
GULF REGISTRY; TASK-FORCE; REPERFUSION; OUTCOMES; DELAYS; FIBRINOLYSIS; GUIDELINES; EXPERIENCE; TRENDS; PCI;
D O I
10.5334/aogh.2632
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in the real-world is unclear. Objectives: To compare the effectiveness of pharmacoinvasive strategy versus primary PCI using a nationwide prospective registry of STEMI patients. Methods: We examined 936 STEMI patients from the reperfusion in ST-elevation myocardial infarction in Kuwait (REPERFUSE Kuwait) registry who underwent either primary PCI or pharmacoinvasive reperfusion. A composite outcome was measured based on death, congestive heart failure, reinfarction or stroke prospectively ascertained during hospital stay and up to one-year follow-up. The association between reperfusion strategy and the composite outcome was assessed using multivariate regression and Poisson proportional hazard model. Results: Compared to the pharmacoinvasive group, those undergoing primary PCI had higher Killip class on presentation and required more blood transfusions during hospitalization. There was no significant difference between primary PCI and pharmacoinvasive strategy with regards to the incidence of the composite outcome during the in-hospital period (RR = 1.0; 95% CI 0.98-1.02; p = 0.96) after adjustment for possible confounders. Over one-year follow-up, the survival of the two groups was not different (p = 0.66). The incidence of major bleeding was similar in both groups. Conclusion: STEMI patients treated with a pharmacoinvasive strategy have comparable outcomes to those treated with primary PCI with no increased risk of major bleeding. These real-world data support the use of a pharmacoinvasive strategy when primary PCI cannot be achieved in a timely fashion.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Safety and efficacy of ticagrelor with emergency percutaneous coronary intervention in senile patients with ST-segment elevation myocardial infarction and dementia
    Wang, Songbai
    Yang, Xiaoming
    Li, Zhijie
    Zhang, Bing
    Cheng, Yu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11831 - 11837
  • [22] Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST-segment elevation at the National Institute of Cardiology (PHASE-MX)
    Baeza-Herrera, Luis A.
    Araiza-Garaygordobil, Diego
    Gopar-Nieto, Rodrigo
    Raymundo-Martinez, Grecia, I
    Loaisiga-Saenz, Arnoldo
    Villalobos-Flores, Abraham
    Martinez-Ramos, Manuel
    Torres-Araujo, Laura, V
    Pohls-Vazquez, Ricardo
    Luna-Herbert, Abraham
    Alonso-Vazquez, Arturo
    Delgado-Cruz, Itzel, V
    Cabello-Lopez, Alejandro
    Martinez-Amezcua, Pablo
    Arias-Mendoza, Maria A.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (02): : 137 - 141
  • [23] A Risk Score for No Reflow in Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention
    Wang, Jin-Wen
    Zhou, Zi-Qiang
    Chen, Yun-Dai
    Wang, Chang-Hua
    Zhu, Xiao-ling
    CLINICAL CARDIOLOGY, 2015, 38 (04) : 208 - 215
  • [24] Results of the Croatian Primary Percutaneous Coronary Intervention Network for Patients With ST-Segment Elevation Acute Myocardial Infarction
    Heitzler, Vjeran Nikolic
    Babic, Zdravko
    Milicic, Davor
    Bergovec, Mijo
    Raguz, Miroslav
    Mirat, Jure
    Strozzi, Maja
    Plazonic, Zeljko
    Giunio, Lovel
    Steiner, Robert
    Starcevic, Boris
    Vukovic, Ivica
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (09) : 1261 - 1267
  • [25] Fibrinolysis vs. primary percutaneous coronary intervention for ST-segment elevation myocardial a infarction cardiogenic shock
    Vallabhajosyula, Saraschandra
    Verghese, Dhiran
    Bell, Malcolm R.
    Murphree, Dennis H.
    Cheungpasitporn, Wisit
    Miller, Paul Elliott
    Dunlay, Shannon M.
    Prasad, Abhiram
    Sandhu, Gurpreet S.
    Gulati, Rajiv
    Singh, Mandeep
    Lerman, Amir
    Gersh, Bernard J.
    Holmes, David R., Jr.
    Barsness, Gregory W.
    ESC HEART FAILURE, 2021, 8 (03): : 2025 - 2035
  • [26] Outcomes of Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients With Previous Coronary Bypass Surgery
    Kohl, Louis P.
    Garberich, Ross F.
    Yang, Hannah
    Sharkey, Scott W.
    Burke, M. Nicholas
    Lips, Daniel L.
    Hildebrandt, David A.
    Larson, David M.
    Henry, Timothy D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (09) : 981 - 987
  • [27] Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST-segment elevation myocardial infarction
    Welsh, Robert C.
    Shavadia, Jay S.
    Zheng, Yinggan
    Tyrrell, Benjamin D.
    Leung, Raymond
    Bainey, Kevin R.
    CLINICAL CARDIOLOGY, 2021, 44 (11) : 1543 - 1550
  • [28] Assessment of the efficacy of primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction based on the ECG analysis
    Madzitow, Hikmat H.
    Alimow, Donyor A.
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2011, 7 (04): : 292 - 296
  • [29] Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease
    Cui, Kongyong
    Lyu, Shuzheng
    Song, Xiantao
    Liu, Hong
    Yuan, Fei
    Xu, Feng
    Zhang, Min
    Wang, Wei
    Zhang, Mingduo
    Zhang, Dongfeng
    Tian, Jinfan
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (03) : 334 - 342
  • [30] Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock
    Kochar, Ajar
    Al-Khalidi, Hussein R.
    Hansen, Steen M.
    Shavadia, Jay S.
    Roettig, Mayme L.
    Fordyce, Christopher B.
    Doerfler, Shannon
    Gersh, Bernard J.
    Henry, Timothy D.
    Berger, Peter B.
    Jollis, James G.
    Granger, Christopher B.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (18) : 1824 - 1833